Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 78 companies made new 52-week lows.
Oncorus Announces Publication In Nature Communications Highlighting The Development Of Its Intravenously Administered Synthetic vRNA/LNP Platform For The Treatment Of Cancer
ANDOVER, Mass., Oct. 07, 2022 (GLOBE NEWSWIRE) -- Oncorus, Inc. (NASDAQ:ONCR), a viral immunotherapies company focused on stimulating the immune system to transform outcomes for cancer patients, today announced the
76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
Gainers
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.
Chardan Sees Over 200% Upside On This Small-Cap Cancer-Focused Stock
Chardan has initiated coverage on Oncorus Inc (NASDAQ:ONCR) with a Buy rating and a price target of $5. The analysts based it…
Chardan Capital Initiates Coverage On Oncorus with Buy Rating, Announces Price Target of $5
Chardan Capital analyst Matthew Barcus initiates coverage on Oncorus (NASDAQ:ONCR) with a Buy rating and announces Price Target of $5.
79 Biggest Movers From Yesterday
Gainers
AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II medical device.